We’re hitting major milestones in #DigitalHealth:
- Top 1: Our in-house medical device software is likely the first of its kind in Germany under MDR! 🇩🇪
- Top 5: Our #CDSS is now among the most used on general wards nationwide.🇩🇪
- Future Top 1: With upcoming AMPEL algorithms, we’re set to become Europe’s CDSS with the highest evidence.🇪🇺
Sadly, these records are only possible because a massive evidence gap exists.. We’re here to close it with #OpenSource!
Why Leipzig University Hospital is committed to manufacturing its own software as medical devices (#SaMD). Prof. Toralf Kirsten (Medical Data Science at Leipzig University) and Martin Federbusch (Head of AMPEL) explain the rationale behind this strategy in this video:
A breakthrough innovation? Our AI medical device "LAMPE" goes live today – the first in-house Clinical Decision Support System (#CDSS) in Germany.
From bold vision to pioneer status. Our goal: an evidence-generating AI infrastructure with a real impact on patient health.
The best part: We'll publish (most of it) #OpenSource and enable all university hospitals to join! 🔓
Read the press release here: https://www.uniklinikum-leipzig.de/einrichtungen/ampel/en/Pages/lampe-press-release.aspx
#CDS #AMPEL #Leipzig #MedicalAI #MDR #SaMD #MDSW #ClinicalAI #eHealth
Our #Fosstodon #Introduction:
Medical teams make hundreds of high-pressure decisions daily. #AMPEL helps making the right decisions.
Developed by the Leipzig University Hospital, this non-profit platform provides all you need for real-time monitoring to catch critical risks in #PatientCare.
By 2026, we are going #OpenSource, bringing #ForEvidence clinical decision support to university clinics with full MDR compliance.
#HealthInnovation #DigitalHealth #MedicalAI #PatientSafety #CDS #CDSS
If we want the most innovation in software, we should tap into the biggest source: Open Source.
With AMPEL, we’re working on bringing this concept into regulated medical software in Germany.
2/2
Where are the obstacles in financing projects on the future topic of #ClinicalAI support?
That's what we asked the experts from the Clinical Decision Support Network (#CDSN).
Our interpretation: Funding generally tends to be divided between academic research and business-driven funding. That presents a challenge for #CDS researchers — because their field often lies right in between!
We’re back from #DMEA – voice almost gone, head full of ideas.
Two days of exciting conversations, valuable exchanges, and genuine interest in our #CDSS, #AMPEL. The discussions showed us that our evidence approach addresses exactly where the greatest need is and where the market currently offers few solutions.
Big thx to everyone who stopped by – for your feedback, interest, and honest questions. We’ve gained a lot and are already looking forward to next year!
AMPEL Platform
Daniel Steinbach
AMPEL-CDSS
hritikasahu